ACA
CLBT icon

Apis Capital Advisors’s Cellebrite CLBT Stock Holding History

Apis Capital Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19M Buy
1,380,000
+560,000
+68% +$8.44M 2.93% 11
2025
Q4 		$14.8M Buy
820,000
+210,000
+34% +$3.77M 2.58% 16
2025
Q3 		$11.3M Buy
610,000
+266,000
+77% +$4.18M 2.5% 16
2025
Q2 		$5.5M Buy
344,000
+54,000
+19% +$963K 1.96% 16
2025
Q1 		$5.63M Buy
+290,000
New +$6.1M 2.73% 9
2024
Q3 		– Sell
-274,000
Closed -$3.27M – 35
2024
Q2 		$3.27M Buy
274,000
+50,000
+22% +$559K 2.42% 16
2024
Q1 		$2.48M Buy
224,000
+24,000
+12% +$245K 1.88% 15
2023
Q4 		$1.73M Buy
+200,000
New +$1.55M 1.82% 19

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Apis Capital Advisors's CLBT Position: Q1 2026 in Review

Apis Capital Advisors increased its Cellebrite (CLBT) stake by 68% in Q1 2026, buying an estimated $8.44M and bringing the position to 1,380,000 shares worth $19M. The position accounts for 2.93% of the portfolio, ranked #11.

Apis Capital Advisors first reported a position in CLBT in Q4 2023 and has held it in 8 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Apis Capital Advisors held 1,380,000 shares of Cellebrite worth $19M as of Q1 2026.
  • Apis Capital Advisors bought 560,000 Cellebrite shares in Q1 2026, an estimated $8.44M.
  • Cellebrite made up 2.93% of Apis Capital Advisors's portfolio in Q1 2026, its #11 holding.
  • Apis Capital Advisors first reported a position in Cellebrite in Q4 2023 and has held it in 8 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Apis Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.